3. Progestins and Neuroprotection: Why the Choice of Progestin Matters

  1. Prof. Dr. Achille G. Gravanis2 and
  2. Prof. Dr. Synthia H. Mellon3
  1. Meharvan Singh

Published Online: 2 FEB 2011

DOI: 10.1002/9783527633968.ch3

Hormones in Neurodegeneration, Neuroprotection, and Neurogenesis

Hormones in Neurodegeneration, Neuroprotection, and Neurogenesis

How to Cite

Singh, M. (2011) Progestins and Neuroprotection: Why the Choice of Progestin Matters, in Hormones in Neurodegeneration, Neuroprotection, and Neurogenesis (eds A. G. Gravanis and S. H. Mellon), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany. doi: 10.1002/9783527633968.ch3

Editor Information

  1. 2

    University of Crete, Department of Pharmacology, School of Medicine, Stavrakia, 71110 Heraklion, Greece

  2. 3

    University of California, Department of Obstetrics, Gynecology, and Reproductive Sciences, The Center for Reproductive Sciences, 513 Parnassus Avenue, San Francisco, CA 94143, USA

Author Information

  1. University of North Texas Health, Science Center, Department of Pharmacology & Neuroscience, Institute for Aging and Alzheimer's Disease Research Center FOR HER, 3500 Camp Bowie Blvd., Fort Worth, TX, 76107, USA

Publication History

  1. Published Online: 2 FEB 2011
  2. Published Print: 14 JAN 2011

ISBN Information

Print ISBN: 9783527326273

Online ISBN: 9783527633968

SEARCH

Keywords:

  • progesterone;
  • progestin;
  • medroxyprogesterone acetate;
  • BDNF;
  • neuroprotection

Summary

This chapter contains sections titled:

  • Introduction

  • The Biology of Progesterone

  • Membrane-Associated Progesterone Receptors

  • Progesterone-Induced Protection

  • Mechanisms Underlying Progesterone's Protective Effects

  • Medroxyprogesterone Acetate

  • Acknowledgments

  • References